In a significant development for the artificial intelligence sector, Vas Narasimhan, Chief Executive Officer of Swiss pharmaceutical giant Novartis, has joined the board of Anthropic, the AI safety company co-founded by former OpenAI executives.
The board expansion signals Anthropic’s institutional ambitions and comes at a critical juncture as the company evaluates a potential initial public offering (IPO) that could materialise as early as this year, according to reports.
Narasimhan’s appointment brings substantial corporate experience and credibility to Anthropic’s leadership structure. His role at Novartis, one of the world’s largest pharmaceutical companies, positions him to provide valuable insights into scaling operations and navigating regulatory frameworks—expertise that could prove crucial as Anthropic prepares for public markets.
For Indian investors tracking global AI developments through platforms like NSE and BSE, this development underscores the growing maturity of the AI sector. An Anthropic IPO would likely influence valuations across the technology and AI ecosystem globally.
The company has been competing aggressively with OpenAI in developing large language models and AI safety protocols. A public offering would provide Anthropic with capital to accelerate research and product development while also offering investors exposure to one of the most promising AI companies globally.
The timing of this board appointment suggests the company is strengthening its governance structure ahead of a potential public debut, a typical precursor to IPO preparations.
Source: Read original